ReviewPulse (Basel, Switzerland)2015
Key Points of the Japanese Society of Hypertension Guidelines for the Management of Hypertension in 2014.
Review in Pulse (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.
- The effect of alcohol dose on the development of hypertension in Asian and Western men: systematic review and meta-analysis.The Korean journal of internal medicine · 2020Pooled it
- Association Between ALDH-2 rs671 and Essential Hypertension Risk or Blood Pressure Levels: A Systematic Review and Meta-Analysis.Frontiers in genetics · 2020Pooled it
- Effects of a dietary supplement on inflammatory marker expression in middle-aged and elderly hypertensive patients.Clinics (Sao Paulo, Brazil) · 2019Trial
- The value of CT-based energy imaging to discriminate dominant side lesions in primary aldosteronism.Frontiers in endocrinology · 2023Article
- Effect of home blood pressure monitoring for blood pressure control in hypertensive patients taking multiple antihypertensive medications including fimasartan (the FORTE study).Clinical hypertension · 2020Article
- Physician and patient perspectives on hypertension management and factors associated with lifestyle modifications in Japan: results from an online survey.Hypertension research : official journal of the Japanese Society of Hypertension · 2020Article
- Age group differences in association between IADL decline and depressive symptoms in community-dwelling elderly.BMC geriatrics · 2019Article
- Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia.Current hypertension reports · 2019Review
- Relationship between non-communicable diseases and background characteristics among homeless people in Nagoya City, Japan.PloS one · 2019Article
- Prevalence and Correlates of Hypertension among Japanese Adults, 1975 to 2010.International journal of environmental research and public health · 2018Article
- Appearance and potential predictors of poorly controlled hypertension at the primary care level in an urban community.Journal of multidisciplinary healthcare · 2018Article
- Tolvaptan is effective in treating patients with refractory ascites due to cirrhosis.Biomedical reports · 2017Article
- Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity.Aging clinical and experimental research · 2017Article
- Vascular Function in Alzheimer's Disease and Vascular Dementia.American journal of Alzheimer's disease and other dementias · 2016Article
- Hypertension Guidelines: Timely New Initiatives from East Asia.Pulse (Basel, Switzerland) · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Japanese Society of Hypertension (JSH) published the new JSH guidelines for the management of hypertension in 2014, which is the revision of the JSH guidelines of 2009. The primary objective of the guideline is to provide physicians the standard treatment strategy of hypertension to prevent the hypertension-related target organ damage and cardiovascular events. The management of hypertension should be performed in hypertensive patients with a blood pressure of ≥140/90 mm Hg. As Asians have a higher prevalence of stroke than of coronary artery disease and stroke is more steeply associated with the level of blood pressure, the target blood pressure should be lower than 130/80 mm Hg for high-risk patients such as those with diabetes or chronic kidney disease. Because of the increasing prevalence of obesity and the related metabolic syndrome, more salt intake and higher salt sensitivity in the population, lifestyle modifications are necessary in hypertensive patients and subjects with high normal blood pressure. This guideline provides evidence-based recommendations for the management of patients with hypertension with the characteristics of our society.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.